Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recruiting

Plain-English translation of NCT07665515 on ClinicalTrials.gov ↗ · Source last updated July 2026 · How we translate trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(10 sites)

United Kingdom

Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital, Cambridge

The University of Edinburgh - Western General Hospital - Edinburgh Cancer Research Centre, Edinburgh

Beatson West of Scotland Cancer Centre, Glasgow

St. James's University Hospital, Leeds

University Hospitals of Leicester NHS Trust -Leicester Royal Infirmary, Leicester